PROCEPT BioRobotics Corp (PRCT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 150M 300M 450M Q3 '21: 27.6M Q4 '21: 34.5M Q1 '22: 41.5M Q2 '22: 49.7M Q3 '22: 61.4M Q4 '22: 75M Q1 '23: 85.2M Q2 '23: 101.6M Q3 '23: 116.4M Q4 '23: 136.2M Q1 '24: 156.3M Q2 '24: 176.6M Q3 '24: 199.8M Q4 '24: 224.5M Q1 '25: 249.1M Q2 '25: 274.9M Q3 '25: 299.9M Q4 '25: 308.1M Q1 '26: 322M Q2 '26: 337.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 80M 160M 240M Q4 '21: 15.9M Q1 '22: 20M Q2 '22: 24.9M Q3 '22: 30.9M Q4 '22: 37.1M Q1 '23: 41.9M Q2 '23: 51.8M Q3 '23: 60.5M Q4 '23: 71M Q1 '24: 83.6M Q2 '24: 96.6M Q3 '24: 114.7M Q4 '24: 137.1M Q1 '25: 156.2M Q2 '25: 176.5M Q3 '25: 193.6M Q4 '25: 196.2M Q1 '26: 206M Q2 '26: 216.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-120M -80M -40M 0 40M 80M 120M Q3 '21: -50.5M Q4 '21: -54.2M Q1 '22: -58.5M Q2 '22: -63.2M Q3 '22: -72.5M Q4 '22: -80.7M Q1 '23: -93.4M Q2 '23: -101.1M Q3 '23: -104.7M Q4 '23: -109.2M Q1 '24: -108.4M Q2 '24: -109.6M Q3 '24: -106.5M Q4 '24: -96.6M Q1 '25: -96.4M Q2 '25: -91.8M Q3 '25: -92.5M Q4 '25: -103.9M Q1 '26: -109M Q2 '26: -114.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-120M -80M -40M 0 40M 80M 120M Q3 '21: -56.8M Q4 '21: -59.9M Q1 '22: -64.2M Q2 '22: -68.8M Q3 '22: -77.3M Q4 '22: -87.2M Q1 '23: -98.5M Q2 '23: -104.6M Q3 '23: -106.6M Q4 '23: -105.9M Q1 '24: -103.4M Q2 '24: -103.7M Q3 '24: -100.1M Q4 '24: -91.4M Q1 '25: -90.2M Q2 '25: -84.1M Q3 '25: -84.6M Q4 '25: -95.6M Q1 '26: -102.5M Q2 '26: -109.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 50M 100M 150M Q3 '21: 15.7M Q4 '21: 18.6M Q1 '22: 21.4M Q2 '22: 24.8M Q3 '22: 30.4M Q4 '22: 37.9M Q1 '23: 43.3M Q2 '23: 49.8M Q3 '23: 55.9M Q4 '23: 65.1M Q1 '24: 72.7M Q2 '24: 79.9M Q3 '24: 85.2M Q4 '24: 87.4M Q1 '25: 92.9M Q2 '25: 98.5M Q3 '25: 106.3M Q4 '25: 111.8M Q1 '26: 116M Q2 '26: 120.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-120M -80M -40M 0 40M 80M 120M Q3 '21: -54.3M Q4 '21: -57.3M Q1 '22: -60.4M Q2 '22: -64.6M Q3 '22: -71.7M Q4 '22: -80.4M Q1 '23: -98.1M Q2 '23: -109.3M Q3 '23: -108.4M Q4 '23: -108M Q1 '24: -104.4M Q2 '24: -91.8M Q3 '24: -91.6M Q4 '24: -99.2M Q1 '25: -83.9M Q2 '25: -83.2M Q3 '25: -71M Q4 '25: -49M Q1 '26: -70.1M Q2 '26: -74.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-150M -100M -50M 0 50M 100M 150M Q3 '21: -54.6M Q4 '21: -57.9M Q1 '22: -61M Q2 '22: -65.3M Q3 '22: -73.8M Q4 '22: -83M Q1 '23: -106M Q2 '23: -122.4M Q3 '23: -125.7M Q4 '23: -133.2M Q1 '24: -126.2M Q2 '24: -109.2M Q3 '24: -103.6M Q4 '24: -103.6M Q1 '25: -88.2M Q2 '25: -89.3M Q3 '25: -79.7M Q4 '25: -58.3M Q1 '26: -80.6M Q2 '26: -84.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q3 '20: 4.3M Q1 '21: 4.8M Q2 '21: 5.6M Q3 '21: 11.6M Q1 '22: 43.9M Q2 '22: 44.3M Q3 '22: 44.6M Q1 '23: 45.1M Q2 '23: 45.2M Q3 '23: 48.3M Q1 '24: 51M Q2 '24: 51.6M Q3 '24: 52M Q1 '25: 54.9M Q2 '25: 55.4M Q3 '25: 55.7M Q1 '26: 56.5M Q2 '26: 57.1M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-10.50 -7.00 -3.50 0.00 3.50 7.00 10.50 Q3 '21: -9.60 Q4 '21: -3.63 Q1 '22: -1.37 Q2 '22: 0.80 Q3 '22: 1.51 Q4 '22: -1.96 Q1 '23: -2.20 Q2 '23: -2.33 Q3 '23: -2.33 Q4 '23: -2.24 Q1 '24: -2.12 Q2 '24: -2.06 Q3 '24: -1.95 Q4 '24: -1.75 Q1 '25: -1.69 Q2 '25: -1.54 Q3 '25: -1.52 Q4 '25: -1.71 Q1 '26: -1.82 Q2 '26: -1.94 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.